About Solowin Holdings - Class A Ordinary Share (SWIN)
Solowin Holdings is a company that focuses on the acquisition, development, and management of technology-driven businesses across various sectors. With an emphasis on innovative solutions and strategic growth, Solowin seeks to leverage emerging technologies to enhance operational efficiency and customer experiences. The company aims to create value for its shareholders by identifying and investing in high-potential opportunities that align with current market trends and consumer demands. Through its diverse portfolio, Solowin contributes to advancements in technology while driving sustainable business practices. Read More
Solowin (NASDAQ: SWIN) is a versatile financial services provider focused on delivering comprehensive investment solutions from traditional finance as well as decentralized finance to high-net-worth and institutional clients. Operating through its wholly owned subsidiary, Solomon JFZ (Asia) Holdings Limited, Solowin is licensed by the Hong Kong Securities and Futures Commission and offers access to a full suite of financial services through its secure, one-stop electronic platform, Solomon Win.
On Thursday, I saw that some penny stocks were already trading over 100 million shares, with others around 30 million. It was clear: penny stocks were in focus. Here’s how the trades went down.
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 150 points on Monday. The Dow traded up 0.40% to 38,870.91 while the NASDAQ rose 1.16% to 16,158.82. The S&P 500 also rose, gaining, 0.86% to 5,161.08.
Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company reported financial fourth-quarter EPS below estimates.
U.S. stocks traded higher midway through trading, with the S&P 500 index gaining around 1% on Monday. The Dow traded up 0.37% to 38,859.32 while the NASDAQ rose 1.61% to 16,231.11. The S&P 500 also rose, gaining, 1.05% to 5,171.00.
Solowin Holdings (NASDAQ:SWIN) shares are falling sharply Thursday following a spike of over 135% last week. Here's a look at what's going on. What To Know: The company announced its expansion into the private wealth management business under its newly formed Hong Kong subsidiary, Solomon Private Wealth Limited. Solowin Holdings said it expects to serve a range of high-net-worth individuals, family offices, and trusts, by offering wealth management services and solutions in traditional and virtual asset classes.
Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.47% to 38,843.54 while the NASDAQ rose 0.66% to 16,137.37. The S&P 500 also rose, gaining, 0.57% to 5,134.03.
Shares of Rush Street Interactive, Inc. (NYSE: RSI) rose sharply in today’s pre-market trading as the company reported better-than-expected fourth-quarter financial results and issued strong revenue guidance for 2024.
Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares tumbled 17.2% to $2.9387 on Wednesday.
Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.
Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.
